Integer Holdings Corporation $ITGR Shares Purchased by Janus Henderson Group PLC

Janus Henderson Group PLC grew its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 408.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,387 shares of the medical equipment provider’s stock after buying an additional 66,999 shares during the quarter. Janus Henderson Group PLC’s holdings in Integer were worth $7,339,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Irenic Capital Management LP acquired a new position in shares of Integer during the 4th quarter valued at $99,109,000. Alliancebernstein L.P. increased its holdings in Integer by 885.1% in the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after purchasing an additional 993,810 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in Integer by 1,141.6% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock valued at $72,076,000 after purchasing an additional 753,081 shares during the period. Millennium Management LLC raised its position in Integer by 3,350.2% in the fourth quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock valued at $53,106,000 after purchasing an additional 657,483 shares during the period. Finally, J. Goldman & Co LP acquired a new position in shares of Integer during the fourth quarter worth about $40,531,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on ITGR shares. Citigroup increased their target price on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Freedom Capital lowered Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. Wells Fargo & Company lifted their price objective on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research note on Tuesday. Finally, Truist Financial cut shares of Integer from a “buy” rating to a “hold” rating and boosted their target price for the stock from $110.00 to $127.00 in a research report on Monday. One research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat, Integer currently has an average rating of “Hold” and a consensus price target of $109.86.

Integer Price Performance

ITGR stock opened at $124.93 on Thursday. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $125.54. The stock’s 50 day moving average is $95.99 and its two-hundred day moving average is $89.84. The company has a market capitalization of $4.24 billion, a PE ratio of 34.13, a P/E/G ratio of 2.98 and a beta of 0.61.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.77% and a net margin of 6.97%.The company had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $451.07 million. During the same period in the prior year, the business posted $1.55 EPS. The business’s revenue was down 2.6% on a year-over-year basis. Analysts predict that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.